Idiopathic Pulmonary Fibrosis Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
TRVI | C | Trevi Therapeutics, Inc. | -0.99 | |
PULM | C | Pulmatrix, Inc. | -4.09 | |
CNTA | D | Centessa Pharmaceuticals plc | -1.16 | |
BIIB | D | Biogen Idec Inc. | 1.70 | |
GYRE | D | Gyre Therapeutics, Inc. | -0.99 | |
VCYT | D | Veracyte, Inc. | 3.42 | |
PLRX | F | Pliant Therapeutics, Inc. | -0.79 | |
GPCR | F | Structure Therapeutics Inc. | 1.67 | |
MORF | F | Morphic Holding, Inc. | 0.33 | |
CTNM | F | Contineum Therapeutics, Inc. | -0.14 |
Related Industries: Biotechnology Drug Manufacturers - Major
Related ETFs - A few ETFs which own one or more of the above listed Idiopathic Pulmonary Fibrosis stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
PBE | C | PowerShares Dynamic Biotech & Genome | 7.11 | |
BIS | D | ProShares UltraShort Nasdaq Biotechnology | 6.77 | |
BBH | B | Market Vectors Biotech ETF | 4.51 | |
IBRN | D | iShares Neuroscience and Healthcare ETF | 4.42 | |
DIP | A | BTD Capital Fund | 4.41 |
Compare ETFs
- Idiopathic Pulmonary Fibrosis
Idiopathic pulmonary fibrosis (IPF) is a type of chronic lung disease characterized by a progressive and irreversible decline in lung function. Symptoms typically include gradual onset of shortness of breath and a dry cough. Other changes may include feeling tired and nail clubbing. Complications may include pulmonary hypertension, heart failure, pneumonia, or pulmonary embolism.The cause is unknown. Risk factors include cigarette smoking, certain viral infections, and a family history of the condition. The underlying mechanism involves scarring of the lungs. Diagnosis requires ruling out other potential causes and may be supported by a CT scan or lung biopsy. It is a type of interstitial lung disease (ILD).People often benefit from pulmonary rehabilitation and supplemental oxygen. Certain medications like pirfenidone or nintedanib may slow the progression of the disease. Lung transplantation may also be an option.About 5 million people are affected globally. The disease newly occurs in about 12 per 100,000 people per year. Those in their 60s and 70s are most commonly affected. Males are affected more often than females. Average life expectancy following diagnosis is about four years.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles